Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Nervous System Drugs > Bisoprolol fumarate for Sale > Bisoprolol fumarate 99% White or almost white powder EP, USP, JP
Bisoprolol fumarate 99% White or almost white powder EP, USP, JP buy - large image1
Bisoprolol fumarate 99% White or almost white powder EP, USP, JP buy - image1

Bisoprolol fumarate 99% White or almost white powder EP, USP, JP

1 Inquiries

Unit Price: Get Latest Price
CAS No.:

104344-23-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Chengdu

Packaging:

10kg/bag in drum

Price valid (until):

2021-12-31

Company Type:
Manufactory
Location:
China
Qualification:
Main Products:

Aprepitant

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Please enter the product introduction information...

    ItemsSpecifications
    AppearanceWhite or almost white powder
    IdentificationIR
    Assay99.0%~101.0%

    Basic Info
    Product Name:

    Bisoprolol fumarate

    Other Name:

    2-Propanol,1-[4-[[2-(1-methylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl)amino]-,(2E)-2-butenedioate (2:1);2-Propanol,1-[4-[[2-(1-methylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl)amino]-,(±)-,(E)-2-butenedioate (2:1) (salt);2-Propanol,1-[4-[[2-(1-methylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl)amino]-,(E)-2-butenedioate (2:1) (salt);2-Propanol,1-[4-[[2-(1-methylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl)amino]-,(2E)-2-butenedioate (2:1) (salt);Bisoprolol fumarate;EMD 33512;Concor;Bisoprolol hemifumarate;Zebeta;Eurtadal;Monocor;Detensiel;Emvoncor;Soprol;Isoten;Emcor;Maintate;1-(4-((2-Isopropoxyethoxy)methyl)phenoxy)-3-(isopropylamino)propan-2-ol hemifumarate;112945-47-8

    CAS No.:

    104344-23-2

    Molecular Formula:

    C18H31NO4.1/2C4H4O4

    InChIKeys:

    InChIKey=RZPZLFIUFMNCLY-WLHGVMLRSA-N

    Molecular Weight:

    441.52

    Exact Mass:

    325.225308

    EC Number:

    1312995-182-4

    DSSTox ID:

    DTXSID1045794

    HScode:

    2922190900

    Categories:

    Nervous System Drugs

    Characteristics
    PSA:

    134.55000

    XLogP3:

    2.46860

    Appearance:

    white solid

    Density:

    1.033 g/cm3

    Melting Point:

    100 °C

    Boiling Point:

    445ºC at 760 mmHg

    Flash Point:

    222.9ºC

    Water Solubility:

    DMSO: >20 mg/mL

    Storage Conditions:

    Store at RT

    Vapor Pressure:

    9.54X10-9 mm Hg at 25 °C (est)

    Toxicity:

    Oral-Rat LD50: 940 mg/kg; Oral-Mouse LD50:678 mg/kg

    Flammability characteristics:

    Combustible; Fire breaks down toxic nitrogen oxide fumes

    PKA:

    9.5None

    Hazard Identification

    Classification of the substance or mixture

    Acute toxicity - Category 4, Oral

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Warning

    Hazard statement(s)

    H302 Harmful if swallowed

    Precautionary statement(s)
    Prevention

    P264 Wash ... thoroughly after handling.

    P270 Do not eat, drink or smoke when using this product.

    Response

    P301+P317 IF SWALLOWED: Get medical help.

    P330 Rinse mouth.

    Storage

    none

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    Aprepitant

    Location:

    No.55, South Shunjiang Avenue, East Economic Development Zone, Dongpo District,Meishan City, Sichuan, 612100, China

    Payment Terms:

    TT against copy of documents,TT against copy of documents,D/P,D/P,L/C,L/C,L/C,L/C,D/A,D/A,D/A,D/A,O/A,O/A,O/A,O/A

    Average lead Time:

    7

    Total Annual Revenue:

    Above $100 million

    Total Employees:

    Above 1000

    Year of Establishment:

    2011

    Sichuan Qingmu Pharmaceutical Co., Ltd., founded in May 2011, is a wholly-owned subsidiary of Chengdu Easton Biopharmaceuticals Co.,Ltd. (Stock code: 688513).

    Qingmu is an innovation driven pharmaceutical company with primary strategic focus on the regulated market, the company speciallize in R&D and manufacturing of generic APIs and advanced intermediates, and also provides CDMO/CMO service for small molecule chemical drugs. 

    Hit API products such as Dabigatran, have been commercialized in regulated markets and China. Qingmu is experienced on exporting API products to more than 40 countries and regions such as Japan, USA, Germany, Spain, the Netherlands, Russia, South Korea, Brazil, etc.

    Focus on business in regulated markets, Qingmu was inspected and approved by US FDA, Korea MFDS, and China NMPA, and also approved by customer audit from China, Europe, USA and Japan, etc. 

  • Inquiry History
    1 Inquiries
    Country Product Purchase Quantity Date Posted
    Egypt

    Bisoprolol Fumarate

    100 G Jul 10, 2025
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.